{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:22:30Z","timestamp":1792074150938,"version":"4.4.0"},"reference-count":166,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,10,1]]},"abstract":"<jats:p>Bronchiolitis is a disorder most commonly caused in infants by viral lower respiratory tract infection. It is the most common lower respiratory infection in this age group. It is characterized by acute inflammation, edema, and necrosis of epithelial cells lining small airways, increased mucus production, and bronchospasm.<\/jats:p><jats:p>The American Academy of Pediatrics convened a committee composed of primary care physicians and specialists in the fields of pulmonology, infectious disease, emergency medicine, epidemiology, and medical informatics. The committee partnered with the Agency for Healthcare Research and Quality and the RTI International-University of North Carolina Evidence-Based Practice Center to develop a comprehensive review of the evidence-based literature related to the diagnosis, management, and prevention of bronchiolitis. The resulting evidence report and other sources of data were used to formulate clinical practice guideline recommendations.<\/jats:p><jats:p>This guideline addresses the diagnosis of bronchiolitis as well as various therapeutic interventions including bronchodilators, corticosteroids, antiviral and antibacterial agents, hydration, chest physiotherapy, and oxygen. Recommendations are made for prevention of respiratory syncytial virus infection with palivizumab and the control of nosocomial spread of infection. Decisions were made on the basis of a systematic grading of the quality of evidence and strength of recommendation. The clinical practice guideline underwent comprehensive peer review before it was approved by the American Academy of Pediatrics.<\/jats:p><jats:p>This clinical practice guideline is not intended as a sole source of guidance in the management of children with bronchiolitis. Rather, it is intended to assist clinicians in decision-making. It is not intended to replace clinical judgment or establish a protocol for the care of all children with this condition. These recommendations may not provide the only appropriate approach to the management of children with bronchiolitis.<\/jats:p>","DOI":"10.1542\/peds.2006-2223","type":"journal-article","created":{"date-parts":[[2006,10,2]],"date-time":"2006-10-02T17:04:22Z","timestamp":1159808662000},"page":"1774-1793","source":"Crossref","is-referenced-by-count":820,"title":["Diagnosis and Management of Bronchiolitis"],"prefix":"10.1542","volume":"118","author":[{"name":"Subcommittee on Diagnosis and Management of Bronchiolitis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2006,10,1]]},"reference":[{"key":"2021120822412620200_R1","unstructured":"Agency for Healthcare Research and Quality. Management of Bronchiolitis in Infants and Children. Evidence Report\/Technology Assessment No. 69. Rockville, MD: Agency for Healthcare Research and Quality; 2003. AHRQ Publication No. 03-E014"},{"key":"2021120822412620200_R2","doi-asserted-by":"crossref","unstructured":"Mullins JA, Lamonte AC, Bresee JS, Anderson LJ. Substantial variability in community respiratory syncytial virus season timing. Pediatr Infect Dis J.\u20082003;22:857\u2013862","DOI":"10.1097\/01.inf.0000090921.21313.d3"},{"key":"2021120822412620200_R3","doi-asserted-by":"crossref","unstructured":"Greenough A, Cox S, Alexander J, et al. Health care utilisation of infants with chronic lung disease, related to hospitalisation for RSV infection. Arch Dis Child.\u20082001;85:463\u2013468","DOI":"10.1136\/adc.85.6.463"},{"key":"2021120822412620200_R4","doi-asserted-by":"crossref","unstructured":"Parrott RH, Kim HW, Arrobio JO, et al. Epidemiology of RSV infection in Washington DC II: infection and disease with respect to age, immunologic status, race and sex. Am J Epidemiol.\u20081973;98:289\u2013300","DOI":"10.1093\/oxfordjournals.aje.a121558"},{"key":"2021120822412620200_R5","doi-asserted-by":"crossref","unstructured":"Meissner HC. Selected populations at increased risk from respiratory syncytial virus infection. Pediatr Infect Dis J.\u20082003;22(2 suppl):S40\u2013S44; discussion S44\u2013S45","DOI":"10.1097\/00006454-200302001-00006"},{"key":"2021120822412620200_R6","doi-asserted-by":"crossref","unstructured":"Shay DK, Holman RC, Roosevelt GE, Clarke MJ, Anderson LJ. Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979\u20131997. J Infect Dis.\u20082001;183:16\u201322","DOI":"10.1086\/317655"},{"key":"2021120822412620200_R7","doi-asserted-by":"crossref","unstructured":"Leader S, Kohlhase K. Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. J Pediatr.\u20082003;143(5 suppl):S127\u2013S132","DOI":"10.1067\/S0022-3476(03)00510-9"},{"key":"2021120822412620200_R8","doi-asserted-by":"crossref","unstructured":"Stang P, Brandenburg N, Carter B. The economic burden of respiratory syncytial virus-associated bronchiolitis hospitalizations. Arch Pediatr Adolesc Med.\u20082001;155:95\u201396","DOI":"10.1001\/archpedi.155.1.95"},{"key":"2021120822412620200_R9","doi-asserted-by":"crossref","unstructured":"Willson DF, Horn SD, Hendley JO, Smout R, Gassaway J. Effect of practice variation on resource utilization in infants for viral lower respiratory illness. Pediatrics.\u20082001;108:851\u2013855","DOI":"10.1542\/peds.108.4.851"},{"key":"2021120822412620200_R10","doi-asserted-by":"crossref","unstructured":"Wang EE, Law BJ, Boucher FD, et al. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study of admission and management variation in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr.\u20081996;129:390\u2013395","DOI":"10.1016\/S0022-3476(96)70071-9"},{"key":"2021120822412620200_R11","doi-asserted-by":"crossref","unstructured":"Brand PLP, Vaessen-Verberne AAPH. Differences in management of bronchiolitis between hospitals in the Netherlands. Eur J Pediatr.\u20082000;159:343\u2013347","DOI":"10.1007\/s004310051284"},{"key":"2021120822412620200_R12","doi-asserted-by":"crossref","unstructured":"Behrendt CE, Decker MD, Burch DJ, Watson PH. International variation in the management of infants hospitalized with respiratory syncytial virus. International RSV Study Group. Eur J Pediatr.\u20081998;157:215\u2013220","DOI":"10.1007\/s004310050798"},{"key":"2021120822412620200_R13","doi-asserted-by":"crossref","unstructured":"Martinez FD. Respiratory syncytial virus bronchiolitis and the pathogenesis of childhood asthma. Pediatr Infect Dis J.\u20082003;22(2 suppl):S76\u2013S82","DOI":"10.1097\/00006454-200302001-00011"},{"key":"2021120822412620200_R14","doi-asserted-by":"crossref","unstructured":"Stein RT, Sherrill D, Morgan WJ, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet.\u20081999;354:541\u2013545","DOI":"10.1016\/S0140-6736(98)10321-5"},{"key":"2021120822412620200_R15","doi-asserted-by":"crossref","unstructured":"Schauer U, Hoffjan S, Bittscheidt J, et al. RSV bronchiolitis and risk of wheeze and allergic sensitization in the first year of life. Eur Respir J.\u20082002;20:1277\u20131283","DOI":"10.1183\/09031936.02.00019902"},{"key":"2021120822412620200_R16","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics, Steering Committee on Quality Improvement and Management. Classifying recommendations for clinical practice guidelines. Pediatrics.\u20082004;114:874\u2013877","DOI":"10.1542\/peds.2004-1260"},{"key":"2021120822412620200_R17","doi-asserted-by":"crossref","unstructured":"Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med.\u20082001;163:1723\u20131729","DOI":"10.1164\/ajrccm.163.7.2011060"},{"key":"2021120822412620200_R18","doi-asserted-by":"crossref","unstructured":"Ashton R, Connolly K. The relation of respiration rate and heart rate to sleep states in the human newborn. Dev Med Child Neurol.\u20081971;13:180\u2013187","DOI":"10.1111\/j.1469-8749.1971.tb03243.x"},{"key":"2021120822412620200_R19","doi-asserted-by":"crossref","unstructured":"Iliff A, Lee VA. Pulse rate, respiratory rate, and body temperature of children between two months and eighteen years of age. Child Dev.\u20081952;23:237\u2013245","DOI":"10.2307\/1126031"},{"key":"2021120822412620200_R20","unstructured":"Rogers MC. Respiratory monitoring. In: Rogers MC, Nichols DG, eds. Textbook of Pediatric Intensive Care. Baltimore, MD: Williams & Wilkins; 1996:332\u2013333"},{"key":"2021120822412620200_R21","doi-asserted-by":"crossref","unstructured":"Berman S, Simoes EA, Lanata C. Respiratory rate and pneumonia in infancy. Arch Dis Child.\u20081991;66:81\u201384","DOI":"10.1136\/adc.66.1.81"},{"key":"2021120822412620200_R22","doi-asserted-by":"crossref","unstructured":"Margolis P, Gadomski A. The rational clinical examination: does this infant have pneumonia?JAMA.\u20081998;279:308\u2013313","DOI":"10.1001\/jama.279.4.308"},{"key":"2021120822412620200_R23","doi-asserted-by":"crossref","unstructured":"Mahabee-Gittens EM, Grupp-Phelan J, Brody AS, et al. Identifying children with pneumonia in the emergency department. Clin Pediatr (Phila).\u20082005;44:427\u2013435","DOI":"10.1177\/000992280504400508"},{"key":"2021120822412620200_R24","doi-asserted-by":"crossref","unstructured":"Brooks AM, McBride JT, McConnochie KM, Aviram M, Long C, Hall CB. Predicting deterioration in previously healthy infants hospitalized with respiratory syncytial virus infection. Pediatrics.\u20081999;104:463\u2013467","DOI":"10.1542\/peds.104.3.463"},{"key":"2021120822412620200_R25","doi-asserted-by":"crossref","unstructured":"Navas L, Wang E, de Carvalho V, Robinson J. Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. Pediatric Investigators Collaborative Network on Infections in Canada. J Pediatr.\u20081992;121:348\u2013354","DOI":"10.1016\/S0022-3476(05)90000-0"},{"key":"2021120822412620200_R26","doi-asserted-by":"crossref","unstructured":"Wang EE, Law BJ, Stephens D. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr.\u20081995;126:212\u2013219","DOI":"10.1016\/S0022-3476(95)70547-3"},{"key":"2021120822412620200_R27","doi-asserted-by":"crossref","unstructured":"Shaw KN, Bell LM, Sherman NH. Outpatient assessment of infants with bronchiolitis. Am J Dis Child.\u20081991;145:151\u2013155","DOI":"10.1001\/archpedi.1991.02160020041012"},{"key":"2021120822412620200_R28","unstructured":"Chan, PW, Lok FY, Khatijah SB. Risk factors for hypoxemia and respiratory failure in respiratory syncytial virus bronchiolitis. Southeast Asian J Trop Med Public Health.\u20082002;33:806\u2013810"},{"key":"2021120822412620200_R29","doi-asserted-by":"crossref","unstructured":"MacDonald NE, Hall CB, Suffin SC, Alexson C, Harris PJ, Manning JA. Respiratory syncytial viral infection in infants with congenital heart disease. N Engl J Med.\u20081982;307:397\u2013400","DOI":"10.1056\/NEJM198208123070702"},{"key":"2021120822412620200_R30","doi-asserted-by":"crossref","unstructured":"Hall CB, Powell KR, MacDonald NE, et al. Respiratory syncytial viral infection in children with compromised immune function. N Engl J Med.\u20081986;315:77\u201381","DOI":"10.1056\/NEJM198607103150201"},{"key":"2021120822412620200_R31","doi-asserted-by":"crossref","unstructured":"McMillan JA, Tristram DA, Weiner LB, Higgins AP, Sandstrom C, Brandon R. Prediction of the duration of hospitalization in patients with respiratory syncytial virus infection: use of clinical parameters. Pediatrics.\u20081988;81:22\u201326","DOI":"10.1542\/peds.81.1.22"},{"key":"2021120822412620200_R32","doi-asserted-by":"crossref","unstructured":"Roback MG, Baskin MN. Failure of oxygen saturation and clinical assessment to predict which patients with bronchiolitis discharged from the emergency department will return requiring admission. Pediatr Emerg Care.\u20081997;13:9\u201311","DOI":"10.1097\/00006565-199702000-00003"},{"key":"2021120822412620200_R33","doi-asserted-by":"crossref","unstructured":"Lowell DI, Lister G, Von Koss H, McCarthy P. Wheezing in infants: the response to epinephrine. Pediatrics.\u20081987;79:939\u2013945","DOI":"10.1542\/peds.79.6.939"},{"key":"2021120822412620200_R34","doi-asserted-by":"crossref","unstructured":"Hall CB, Hall WJ, Speers DM. Clinical and physiological manifestations of bronchiolitis and pneumonia: outcome of respiratory syncytial virus. Am J Dis Child.\u20081979;133:798\u2013802","DOI":"10.1001\/archpedi.1979.02130080038006"},{"key":"2021120822412620200_R35","doi-asserted-by":"crossref","unstructured":"Schroeder AR, Marmor AK, Pantell RH, Newman TB. Impact of pulse oximetry and oxygen therapy on length of stay in bronchiolitis hospitalizations. Arch Pediatr Adolesc Med.\u20082004;158:527\u2013530","DOI":"10.1001\/archpedi.158.6.527"},{"key":"2021120822412620200_R36","doi-asserted-by":"crossref","unstructured":"Dawson KP, Long A, Kennedy J, Mogridge N. The chest radiograph in acute bronchiolitis. J Paediatr Child Health.\u20081990;26:209\u2013211","DOI":"10.1111\/j.1440-1754.1990.tb02431.x"},{"key":"2021120822412620200_R37","doi-asserted-by":"crossref","unstructured":"Roosevelt G, Sheehan K, Grupp-Phelan J, Tanz RR, Listernic R. Dexamethasone in bronchiolitis: a randomized controlled trial. Lancet.\u20081996;348:292\u2013305","DOI":"10.1016\/S0140-6736(96)02285-4"},{"key":"2021120822412620200_R38","doi-asserted-by":"crossref","unstructured":"Swingler GH, Hussey GD, Zwarenstein M. Randomised controlled trial of clinical outcome after chest radiograph in ambulatory acute lower-respiratory infection in children. Lancet.\u20081998;351:404\u2013408","DOI":"10.1016\/S0140-6736(97)07013-X"},{"key":"2021120822412620200_R39","doi-asserted-by":"crossref","unstructured":"Mallory MD, Shay DK, Garrett J, Bordley WC. Bronchiolitis management preferences and the influence of pulse oximetry and respiratory rate on the decision to admit. Pediatrics.\u20082003;111(1). Available at: www.pediatrics.org\/cgi\/content\/full\/111\/1\/e45","DOI":"10.1542\/peds.111.1.e45"},{"key":"2021120822412620200_R40","doi-asserted-by":"crossref","unstructured":"Bordley WC, Viswanathan M, King VJ, et al. Diagnosis and testing in bronchiolitis: a systematic review. Arch Pediatr Adolesc Med.\u20082004;158:119\u2013126","DOI":"10.1001\/archpedi.158.2.119"},{"key":"2021120822412620200_R41","doi-asserted-by":"crossref","unstructured":"Liebelt E, Qi K, Harvey K. Diagnostic testing for serious bacterial infections in infants aged 90 days or younger with bronchiolitis. Arch Pediatr Adolesc Med.\u20081999;153:525\u2013530","DOI":"10.1001\/archpedi.153.5.525"},{"key":"2021120822412620200_R42","doi-asserted-by":"crossref","unstructured":"Kuppermann N, Bank DE, Walton EA, Senac MO Jr, McCaslin I. Risks for bacteremia and urinary tract infections in young febrile children with bronchiolitis. Arch Pediatr Adolesc Med.\u20081997;151:1207\u20131214","DOI":"10.1001\/archpedi.1997.02170490033006"},{"key":"2021120822412620200_R43","doi-asserted-by":"crossref","unstructured":"Levine DA, Platt SL, Dayan PS, et al. Risk of serious bacterial infection in young febrile infants with respiratory syncytial virus infections. Pediatrics.\u20082004;113:1728\u20131734","DOI":"10.1542\/peds.113.6.1728"},{"key":"2021120822412620200_R44","doi-asserted-by":"crossref","unstructured":"Kellner JD, Ohlsson A, Gadomski AM, Wang EE. Bronchodilators for bronchiolitis. Cochrane Database Syst Rev.\u20082000;(2):CD001266","DOI":"10.1002\/14651858.CD001266"},{"key":"2021120822412620200_R45","doi-asserted-by":"crossref","unstructured":"Alario AJ, Lewander WJ, Dennehy P, Seifer R, Mansell AL. The efficacy of nebulized metaproterenol in wheezing infants and young children. Am J Dis Child.\u20081992;146:412\u2013418","DOI":"10.1001\/archpedi.1992.02160160032008"},{"key":"2021120822412620200_R46","doi-asserted-by":"crossref","unstructured":"Henry RL, Milner AD, Stokes GM. Ineffectiveness of ipratropium bromide in acute bronchiolitis. Arch Dis Child.\u20081983;58:925\u2013926","DOI":"10.1136\/adc.58.11.925"},{"key":"2021120822412620200_R47","doi-asserted-by":"crossref","unstructured":"Klassen TP, Rowe PC, Sutcliffe T, Ropp LJ, McDowell IW, Li MM. Randomized trial of salbutamol in acute bronchiolitis. J Pediatr.\u20081991;118:807\u2013811","DOI":"10.1016\/S0022-3476(05)80051-4"},{"key":"2021120822412620200_R48","unstructured":"Lines DR, Kattampallil JS, Liston P. Efficacy of nebulized salbutamol in bronchiolitis. Pediatr Rev Commun.\u20081990;5:121\u2013129"},{"key":"2021120822412620200_R49","doi-asserted-by":"crossref","unstructured":"Mallol J, Barrueo L, Girardi G, et al. Use of nebulized bronchodilators in infants under 1 year of age: analysis of four forms of therapy. Pediatr Pulmonol.\u20081987;3:298\u2013303","DOI":"10.1002\/ppul.1950030504"},{"key":"2021120822412620200_R50","doi-asserted-by":"crossref","unstructured":"Tal A, Bavilski C, Yohai D, Bearman JE, Gorodischer R, Moses SW. Dexamethasone and salbutamol in the treatment of acute wheezing in infants. Pediatrics.\u20081983;71:13\u201318","DOI":"10.1542\/peds.71.1.13"},{"key":"2021120822412620200_R51","doi-asserted-by":"crossref","unstructured":"Wainwright C, Altamirano L, Cheney M, et al. A multicenter, randomized, double-blind, controlled trial of nebulized epinephrine in infants with acute bronchiolitis. N Engl J Med.\u20082003;349:27\u201335","DOI":"10.1056\/NEJMoa022226"},{"key":"2021120822412620200_R52","doi-asserted-by":"crossref","unstructured":"Schweich PJ, Hurt TL, Walkley EI, Mullen N, Archibald LF. The use of nebulized albuterol in wheezing infants. Pediatr Emerg Care.\u20081992;8:184\u2013188","DOI":"10.1097\/00006565-199208000-00003"},{"key":"2021120822412620200_R53","doi-asserted-by":"crossref","unstructured":"Schuh S, Canny G, Reisman JJ, et al. Nebulized albuterol in acute bronchiolitis. J Pediatr.\u20081990;117:633\u2013637","DOI":"10.1016\/S0022-3476(05)80706-1"},{"key":"2021120822412620200_R54","doi-asserted-by":"crossref","unstructured":"Gadomski AM, Lichtenstein R, Horton L, King J, Keane V, Permutt T. Efficacy of albuterol in the management of bronchiolitis. Pediatrics.\u20081994;93:907\u2013912","DOI":"10.1542\/peds.93.6.907"},{"key":"2021120822412620200_R55","doi-asserted-by":"crossref","unstructured":"Dobson JV, Stephens-Groff SM, McMahon SR, Stemmler MM, Brallier SL, Bay C. The use of albuterol in hospitalized infants with bronchiolitis. Pediatrics.\u20081998;101:361\u2013368","DOI":"10.1542\/peds.101.3.361"},{"key":"2021120822412620200_R56","doi-asserted-by":"crossref","unstructured":"Flores G, Horwitz RI. Efficacy of beta2-agonists in bronchiolitis: a reappraisal and meta-analysis. Pediatrics.\u20081997;l00:233\u2013239","DOI":"10.1542\/peds.100.2.233"},{"key":"2021120822412620200_R57","doi-asserted-by":"crossref","unstructured":"Kristjansson S, Lodrup Carlsen KC, Wennergren G, Strannegard IL, Carlsen KH. Nebulised racemic adrenaline in the treatment of acute bronchiolitis in infants and toddlers. Arch Dis Child.\u20081993;69:650\u2013654","DOI":"10.1136\/adc.69.6.650"},{"key":"2021120822412620200_R58","doi-asserted-by":"crossref","unstructured":"Menon K, Sutcliffe T, Klassen TP. A randomized trial comparing the efficacy of epinephrine with salbutamol in the treatment of acute bronchiolitis. J Pediatr.\u20081995;126:1004\u20131007","DOI":"10.1016\/S0022-3476(95)70234-2"},{"key":"2021120822412620200_R59","doi-asserted-by":"crossref","unstructured":"Numa AH, Williams GD, Dakin CJ. The effect of nebulized epinephrine on respiratory mechanics and gas exchange in bronchiolitis. Am J Respir Crit Care Med.\u20082001;164:86\u201391","DOI":"10.1164\/ajrccm.164.1.2008090"},{"key":"2021120822412620200_R60","doi-asserted-by":"crossref","unstructured":"Wohl ME, Chernick V. State of the art: bronchiolitis. Am Rev Respir Dis.\u20081978;118:759\u2013781","DOI":"10.1164\/arrd.1978.118.4.759"},{"key":"2021120822412620200_R61","doi-asserted-by":"crossref","unstructured":"Hartling L, Wiebe N, Russell K, Patel H, Klassen T. A meta-analysis of randomized controlled trials evaluating the efficacy of epinephrine for the treatment of acute viral bronchiolitis. Arch Pediatr Adolesc Med.\u20082003;157:957\u2013967","DOI":"10.1001\/archpedi.157.10.957"},{"key":"2021120822412620200_R62","doi-asserted-by":"crossref","unstructured":"Hartling L, Wiebe N, Russell K, Patel H, Klassen TP. Epinephrine for bronchiolitis. Cochrane Database Syst Rev.\u20082004;(1):CD003123","DOI":"10.1002\/14651858.CD003123.pub2"},{"key":"2021120822412620200_R63","doi-asserted-by":"crossref","unstructured":"Bierman CW, Pierson WE. The pharmacological management of status asthmaticus in children. Pediatrics.\u20081974;54:245\u2013247","DOI":"10.1542\/peds.54.2.245"},{"key":"2021120822412620200_R64","doi-asserted-by":"crossref","unstructured":"Schuh S, Coates AL, Binnie R, et al. Efficacy of oral dexamethasone in outpatients with acute bronchiolitis. J Pediatr.\u20082002;140:27\u201332","DOI":"10.1067\/mpd.2002.120271"},{"key":"2021120822412620200_R65","doi-asserted-by":"crossref","unstructured":"Gorelick MH, Stevens MW, Schultz TR, Scribano PV. Performance of a novel clinical score, the Pediatric Asthma Severity Score (PASS) in the evaluation of acute asthma. Acad Emerg Med.\u20082004;11:10\u201318","DOI":"10.1111\/j.1553-2712.2004.tb01365.x"},{"key":"2021120822412620200_R66","unstructured":"Cincinnati Children's Hospital Medical Center. Evidence-based clinical practice guideline for the medical management of infants less than 1 year with a first episode of bronchiolitis. Available at: www.cincinnatichildrens.org\/NR\/rdonlyres\/B3EC347E-65AC-490A-BC4C-55C3AF4B76D5\/0\/BronchRS.pdf. Accessed June 21, 2006"},{"key":"2021120822412620200_R67","unstructured":"Goh A, Chay OM, Foo AL, Ong EK. Efficacy of bronchodilators in the treatment of bronchiolitis. Singapore Med J.\u20081997;38:326\u2013328"},{"key":"2021120822412620200_R68","doi-asserted-by":"crossref","unstructured":"Chowdhury D, al Howasi M, Khalil M, al-Frayh AS, Chowdhury S, Ramia S. The role of bronchodilators in the management of bronchiolitis: a clinical trial. Ann Trop Paediatr.\u20081995;15:77\u201384","DOI":"10.1080\/02724936.1995.11747752"},{"key":"2021120822412620200_R69","doi-asserted-by":"crossref","unstructured":"Wang EE, Milner R, Allen U, Maj H. Bronchodialtors for treatment of mild bronchiolitis: a factorial randomized trial. Arch Dis Child.\u20081992;67:289\u2013293","DOI":"10.1136\/adc.67.3.289"},{"key":"2021120822412620200_R70","doi-asserted-by":"crossref","unstructured":"Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis associated hospitalizations among US children, 1980\u20131996. JAMA.\u20081999;282:1440\u20131446","DOI":"10.1001\/jama.282.15.1440"},{"key":"2021120822412620200_R71","doi-asserted-by":"crossref","unstructured":"Patel H, Platt R, Lozano JM, Wang EE. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev.\u20082004;(3):CD004878","DOI":"10.1002\/14651858.CD004878"},{"key":"2021120822412620200_R72","doi-asserted-by":"crossref","unstructured":"Garrison MM, Christakis DA, Harvey E, Cummings P, Davis RL. Systemic corticosteroids in infant bronchiolitis: a meta-analysis. Pediatrics.\u20082000;105(4). Available at: www.pediatrics.org\/cgi\/content\/full\/105\/4\/e44","DOI":"10.1542\/peds.105.4.e44"},{"key":"2021120822412620200_R73","doi-asserted-by":"crossref","unstructured":"Berger I, Argaman Z, Schwartz SB, et al. Efficacy of corticosteroids in acute bronchiolitis: short-term and long-term follow-up. Pediatr Pulmonol.\u20081998;26:162\u2013166","DOI":"10.1002\/(SICI)1099-0496(199809)26:3<162::AID-PPUL2>3.0.CO;2-N"},{"key":"2021120822412620200_R74","doi-asserted-by":"crossref","unstructured":"Bulow SM, Nir M, Levin E, et al. Prednisolone treatment of respiratory syncytial virus infection: a randomized controlled trial of 147 infants. Pediatrics.\u20081999;104(6). Available at: www.pediatrics.org\/cgi\/content\/full\/105\/6\/e77","DOI":"10.1542\/peds.104.6.e77"},{"key":"2021120822412620200_R75","doi-asserted-by":"crossref","unstructured":"Connolly JH, Field CMB, Glasgoe JFT, Slattery M, MacLynn DM. A double blind trial of prednisolone in epidemic bronchiolitis due to respiratory syncytial virus. Acta Paediatr Scand.\u20081969;58:116\u2013120","DOI":"10.1111\/j.1651-2227.1969.tb04693.x"},{"key":"2021120822412620200_R76","doi-asserted-by":"crossref","unstructured":"Dabbous JA, Tkachyk JS, Stamm SJ. A double blind study on the effects of corticosteroids in the treatment of bronchiolitis. Pediatrics.\u20081966;37:477\u2013484","DOI":"10.1542\/peds.37.3.477"},{"key":"2021120822412620200_R77","doi-asserted-by":"crossref","unstructured":"DeBoeck K, Van der Aa N, Van Lierde S, Corbeel L, Eeckels R. Respiratory syncytial virus bronchiolitis: a double-blind dexamethasone efficacy study. J Pediatr.\u20081997;131:919\u2013921","DOI":"10.1016\/S0022-3476(97)70044-1"},{"key":"2021120822412620200_R78","doi-asserted-by":"crossref","unstructured":"Goebel J, Estrada B, Quinonez J, Nagji N, Sanford D, Boerth RC. Prednisolone plus albuterol versus albuterol alone in mild to moderate bronchiolitis. Clin Pediatr (Phila).\u20082000;39:213\u2013220","DOI":"10.1177\/000992280003900404"},{"key":"2021120822412620200_R79","doi-asserted-by":"crossref","unstructured":"Klassen TP, Sutcliffe T, Watters LK, Wells GA, Allen UD, Li MM. Dexamethasone in salbutamol-treated inpatients with acute bronchiolitis: a randomized controlled trial. J Pediatr.\u20081997;130:191\u2013196","DOI":"10.1016\/S0022-3476(97)70342-1"},{"key":"2021120822412620200_R80","doi-asserted-by":"crossref","unstructured":"Leer JA, Bloomfield N, Green JL, et al. Corticosteroid treatment in bronchiolitis. Am J Dis Child.\u20081969;117:495\u2013503","DOI":"10.1001\/archpedi.1969.02100030497001"},{"key":"2021120822412620200_R81","doi-asserted-by":"crossref","unstructured":"Springer C, Bar-Yishay E, Uwayyed K, Avital A, Vilozni D, Godfrey S. Corticosteroids do not affect the clinical or physiological status of infants with bronchiolitis. Pediatr Pulmonol.\u20081990;9:181\u2013185","DOI":"10.1002\/ppul.1950090311"},{"key":"2021120822412620200_R82","doi-asserted-by":"crossref","unstructured":"Van Woensel JBM, Wolfs TFW, van Aaldersen WMC, Brand PLP, Kimpen JLL. Randomised double blind placebo controlled trial of prednisolone in children admitted to hospital with respiratory syncytial virus bronchiolitis. Thorax.\u20081997;52:634\u2013637","DOI":"10.1136\/thx.52.7.634"},{"key":"2021120822412620200_R83","unstructured":"de Blic J. Use of corticoids in acute bronchiolitis in infants [in French]. Arch Pediatr.\u20082001;9 (suppl 1):49S\u201354S"},{"key":"2021120822412620200_R84","unstructured":"Chao LC, Lin YZ, Wu WF, Huang FY. Efficacy of nebulized budesonide in hospitalized infants and children younger than 24 months with bronchiolitis. Acta Paediatr Taiwan.\u20082003;44:332\u2013335"},{"key":"2021120822412620200_R85","doi-asserted-by":"crossref","unstructured":"King VJ, Viswanathan M, Bordley WC, et al. Pharmacologic treatment of bronchiolitis in infants and children. Arch Pediatr Adolesc Med.\u20082004;158:127\u2013137","DOI":"10.1001\/archpedi.158.2.127"},{"key":"2021120822412620200_R86","doi-asserted-by":"crossref","unstructured":"Hall CB, McBride JT, Walsh EE, et al. Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection: a randomized double-blind study. N Engl J Med.\u20081983;308:1443\u20131447","DOI":"10.1056\/NEJM198306163082403"},{"key":"2021120822412620200_R87","doi-asserted-by":"crossref","unstructured":"Taber LH, Knight V, Gilbert BE, et al. Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants. Pediatrics.\u20081983;72:613\u2013618","DOI":"10.1542\/peds.72.5.613"},{"key":"2021120822412620200_R88","doi-asserted-by":"crossref","unstructured":"Barry W, Cockburn F, Cornall R, et al. Ribavirin aerosol for acute bronchiolitis. Arch Dis Child.\u20081986;61:593\u2013597","DOI":"10.1136\/adc.61.6.593"},{"key":"2021120822412620200_R89","doi-asserted-by":"crossref","unstructured":"Rodriguez WJ, Kim HW, Brandt CD, et al. Aerosolized ribavirin in the treatment of patients with respiratory syncytial virus disease. Pediatr Infect Dis J.\u20081987;6:159\u2013163","DOI":"10.1097\/00006454-198702000-00004"},{"key":"2021120822412620200_R90","doi-asserted-by":"crossref","unstructured":"Smith DW, Frankel LR, Mathers LH, Tang AT, Ariagno RL, Prober CG. A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection. N Engl J Med.\u20081991;325:24\u201329","DOI":"10.1056\/NEJM199107043250105"},{"key":"2021120822412620200_R91","doi-asserted-by":"crossref","unstructured":"Janai HK, Stutman HR, Zeleska M, et al. Ribavirin effect on pulmonary function in young infants with respiratory syncytial virus bronchiolitis. Pediatr Infect Dis J.\u20081993;12:214\u2013218","DOI":"10.1097\/00006454-199303000-00008"},{"key":"2021120822412620200_R92","doi-asserted-by":"crossref","unstructured":"Meert KL, Sarnaik AP, Gelmini MJ, Lieh-Lai MW. Aerosolized ribavirin in mechanically ventilated children with respiratory syncytial virus lower respiratory tract disease: a double-blind, randomized trial. Crit Care Med.\u20081994;22:566\u2013572","DOI":"10.1097\/00003246-199404000-00010"},{"key":"2021120822412620200_R93","doi-asserted-by":"crossref","unstructured":"Guerguerian AM, Gauthier M, Lebel MH, Farrell CA, Lacroix J. Ribavirin in ventilated respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med.\u20081999;160:829\u2013834","DOI":"10.1164\/ajrccm.160.3.9810013"},{"key":"2021120822412620200_R94","doi-asserted-by":"crossref","unstructured":"Everard ML, Swarbrick A, Rigby AS, Milner AD. The effect of ribavirin to treat previously healthy infants admitted with acute bronchiolitis on acute and chronic respiratory morbidity. Respir Med.\u20082001;95:275\u2013280","DOI":"10.1053\/rmed.2001.1033"},{"key":"2021120822412620200_R95","doi-asserted-by":"crossref","unstructured":"Rodriguez WJ, Arrobio J, Fink R, Kim HW, Milburn C. Prospective follow-up and pulmonary functions from a placebo-controlled randomized trial of ribavirin therapy in respiratory syncytial virus bronchiolitis. Arch Pediatr Adolesc Med.\u20081999;153:469\u2013474","DOI":"10.1001\/archpedi.153.5.469"},{"key":"2021120822412620200_R96","doi-asserted-by":"crossref","unstructured":"Edell D, Khoshoo V, Ross G, Salter K. Early ribavirin treatment of bronchiolitis. Chest.\u20082002;122:935\u2013939","DOI":"10.1378\/chest.122.3.935"},{"key":"2021120822412620200_R97","doi-asserted-by":"crossref","unstructured":"Hall CB, McBride JT, Gala CL, Hildreth SW, Schnabel KC. Ribavirin treatment of respiratory syncytial viral infection in infants with underlying cardiopulmonary disease. JAMA.\u20081985;254:3047\u20133051","DOI":"10.1001\/jama.254.21.3047"},{"key":"2021120822412620200_R98","doi-asserted-by":"crossref","unstructured":"Groothuis JR, Woodin KA, Katz R, et al. Early ribavirin treatment of respiratory syncytial virus infection in high-risk children. J Pediatr.\u20081990;117:792\u2013798","DOI":"10.1016\/S0022-3476(05)83347-5"},{"key":"2021120822412620200_R99","doi-asserted-by":"crossref","unstructured":"Long CE, Voter KZ, Barker WH, Hall CB. Long term follow-up of children hospitalized with respiratory syncytial virus lower respiratory tract infection and randomly treated with ribavirin and placebo. Pediatr Infect Dis J.\u20081997;16:1023\u20131028","DOI":"10.1097\/00006454-199711000-00004"},{"key":"2021120822412620200_R100","doi-asserted-by":"crossref","unstructured":"Bradley JS, Conner JD, Compagiannis LS, Eiger LL. Exposure of health care workers to ribavirin during therapy for respiratory syncytial virus infections. Antimicrob Agents Chemother.\u20081990;34:668\u2013670","DOI":"10.1128\/AAC.34.4.668"},{"key":"2021120822412620200_R101","doi-asserted-by":"crossref","unstructured":"Rodriguez WJ, Bui RHD, Conner JD, et al. Environmental exposure of primary care personnel to ribavirin aerosol when supervising treatment of infants with respiratory syncytial virus infections. Antimicrob Agents Chemother.\u20081987;31:1143\u20131146","DOI":"10.1128\/AAC.31.7.1143"},{"key":"2021120822412620200_R102","doi-asserted-by":"crossref","unstructured":"Feldstein TJ, Swegarden JL, Atwood GF, Peterson CD. Ribavirin therapy: implementation of hospital guidelines and effect on usage and cost of therapy. Pediatrics.\u20081995;96:14\u201317","DOI":"10.1542\/peds.96.1.14"},{"key":"2021120822412620200_R103","doi-asserted-by":"crossref","unstructured":"Putto A, Ruuskanen O, Meruman O. Fever in respiratory virus infections. Am J Dis Child.\u20081986;140:1159\u20131163","DOI":"10.1001\/archpedi.1986.02140250085040"},{"key":"2021120822412620200_R104","doi-asserted-by":"crossref","unstructured":"LaVia W, Marks MI, Stutman HR. Respiratory syncytial virus puzzle: clinical features, pathophysiology, treatment, and prevention. J Pediatr.\u20081992;121:503\u2013510","DOI":"10.1016\/S0022-3476(05)81135-7"},{"key":"2021120822412620200_R105","doi-asserted-by":"crossref","unstructured":"Nichol KP, Cherry JD. Bacterial-viral interrelations in respiratory infections in children. N Engl J Med.\u20081967;277:667\u2013672","DOI":"10.1056\/NEJM196709282771301"},{"key":"2021120822412620200_R106","doi-asserted-by":"crossref","unstructured":"Field CM, Connolly JH, Murtagh G, Slattery CM, Turkington EE. Antibiotic treatment of epidemic bronchiolitis. Br Med J.\u20081966;5479:83\u201385","DOI":"10.1136\/bmj.1.5479.83"},{"key":"2021120822412620200_R107","doi-asserted-by":"crossref","unstructured":"Friis B, Andersen P. Brenoe E, et al. Antibiotic treatment of pneumonia and bronchiolitis. A prospective randomised study. Arch Dis Child.\u20081984;59:1038\u20131045","DOI":"10.1136\/adc.59.11.1038"},{"key":"2021120822412620200_R108","doi-asserted-by":"crossref","unstructured":"Antonow JA, Hansen K, McKinstry CA, Byington CL. Sepsis evaluations in hospitalized infants with bronchiolitis. Pediatr Infect Dis J.\u20081998;17:231\u2013236","DOI":"10.1097\/00006454-199803000-00011"},{"key":"2021120822412620200_R109","doi-asserted-by":"crossref","unstructured":"Greenes DS, Harper MB. Low risk of bacteremia in febrile children with recognizable viral syndromes. Pediatr Infect Dis J.\u20081999;18:258\u2013261","DOI":"10.1097\/00006454-199903000-00010"},{"key":"2021120822412620200_R110","doi-asserted-by":"crossref","unstructured":"Purcell K, Fergie J. Concurrent serious bacterial infections in 2396 infants and children hospitalized with respiratory syncytial virus lower respiratory tract infections. Arch Pediatr Adolesc Med.\u20082002;156:322\u2013324","DOI":"10.1001\/archpedi.156.4.322"},{"key":"2021120822412620200_R111","doi-asserted-by":"crossref","unstructured":"Purcell K, Fergie J. Concurrent serious bacterial infections in 912 infants and children hospitalized for treatment of respiratory syncytial virus lower respiratory tract infection. Pediatr Infect Dis J.\u20082004;23:267\u2013269","DOI":"10.1097\/01.inf.0000116759.21252.29"},{"key":"2021120822412620200_R112","doi-asserted-by":"crossref","unstructured":"Titus MO, Wright SW. Prevalence of serious bacterial infections in febrile infants with respiratory syncytial virus infections. Pediatrics.\u20082003;112:282\u2013284","DOI":"10.1542\/peds.112.2.282"},{"key":"2021120822412620200_R113","doi-asserted-by":"crossref","unstructured":"Melendez E, Harper MB. Utility of sepsis evaluation in infants 90 days of age or younger with fever and clinical bronchiolitis. Pediatr Infect Dis J.\u20082003;22:1053\u20131056","DOI":"10.1097\/01.inf.0000101296.68993.4d"},{"key":"2021120822412620200_R114","doi-asserted-by":"crossref","unstructured":"Hall CB, Powell KR, Schnabel KC, Gala CL, Pincus PH. Risk of serious bacterial infection in infants hospitalized with respiratory syncytial viral infection. J Pediatr.\u20081988;113:266\u2013271","DOI":"10.1016\/S0022-3476(88)80263-4"},{"key":"2021120822412620200_R115","unstructured":"Hall CB. Respiratory syncytial virus: a continuing culprit and conundrum. J Pediatr.\u20081999;135(2 pt 2):2\u20137"},{"key":"2021120822412620200_R116","doi-asserted-by":"crossref","unstructured":"Davies HD, Matlow A, Petric M, Glazier R, Wang EE. Prospective comparative study of viral, bacterial and atypical organisms identified in pneumonia and bronchiolitis in hospitalized Canadian infants. Pediatr Infect Dis J.\u20081996;15:371\u2013375","DOI":"10.1097\/00006454-199604000-00017"},{"key":"2021120822412620200_R117","doi-asserted-by":"crossref","unstructured":"Andrade MA, Hoberman A, Glustein J, Paradise JL, Wald ER. Acute otitis media in children with bronchiolitis. Pediatrics.\u20081998;101:617\u2013619","DOI":"10.1542\/peds.101.4.617"},{"key":"2021120822412620200_R118","doi-asserted-by":"crossref","unstructured":"Shazberg G, Revel-Vilk S, Shoseyov D, Ben-Ami A, Klar A, Hurvitz H. The clinical course of bronchiolitis associated with otitis media. Arch Dis Child.\u20082000;83:317\u2013319","DOI":"10.1136\/adc.83.4.317"},{"key":"2021120822412620200_R119","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics, Subcommittee on Management of Acute Otitis Media. Diagnosis and management of acute otitis media. Pediatrics.\u20082004;113:1451\u20131465","DOI":"10.1542\/peds.113.5.1451"},{"key":"2021120822412620200_R120","doi-asserted-by":"crossref","unstructured":"Khoshoo V, Edell D. Previously healthy infants may have increased risk of aspiration during respiratory syncytial viral bronchiolitis. Pediatrics.\u20081999;104:1389\u20131390","DOI":"10.1542\/peds.104.6.1389"},{"key":"2021120822412620200_R121","doi-asserted-by":"crossref","unstructured":"Gozal D, Colin AA, Jaffe M, Hochberg Z. Water, electrolyte, and endocrine homeostasis in infants with bronchiolitis. Pediatr Res.\u20081990;27:204\u2013209","DOI":"10.1203\/00006450-199002000-00023"},{"key":"2021120822412620200_R122","doi-asserted-by":"crossref","unstructured":"van Steensel-Moll HA, Hazelzet JA, van der Voort E, Neijens HJ, Hackeng WH. Excessive secretion of antidiuretic hormone in infections with respiratory syncytial virus. Arch Dis Child.\u20081990;65:1237\u20131239","DOI":"10.1136\/adc.65.11.1237"},{"key":"2021120822412620200_R123","doi-asserted-by":"crossref","unstructured":"Perotta C, Ortiz Z, Roque M. Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old. Cochrane Database Syst Rev.\u20082005;(2):CD004873","DOI":"10.1002\/14651858.CD004873.pub2"},{"key":"2021120822412620200_R124","doi-asserted-by":"crossref","unstructured":"Nicholas KJ, Dhouieb MO, Marshal TG, Edmunds AT, Grant MB. An evaluation of chest physiotherapy in the management of acute bronchiolitis: changing clinical practice. Physiotherapy.\u20081999;85:669\u2013674","DOI":"10.1016\/S0031-9406(05)61230-8"},{"key":"2021120822412620200_R125","doi-asserted-by":"crossref","unstructured":"Webb MS, Martin JA, Cartlidge PH, Ng YK, Wright NA. Chest physiotherapy in acute bronchiolitis. Arch Dis Child.\u20081985;60:1078\u20131079","DOI":"10.1136\/adc.60.11.1078"},{"key":"2021120822412620200_R126","unstructured":"Bohe L, Ferrero ME, Cuestas E, Polliotto L, Genoff M. Indications of conventional chest physiotherapy in acute bronchiolitis [in Spanish]. Medicina (B Aires).\u20082004;64:198\u2013200"},{"key":"2021120822412620200_R127","doi-asserted-by":"crossref","unstructured":"O'Brien LM, Stebbens VA, Poets CF, Heycock EG, Southall DP. Oxygen saturation during the first 24 hours of life. Arch Dis Child Fetal Neonatal Ed.\u20082000;83:F35\u2013F38","DOI":"10.1136\/fn.83.1.F35"},{"key":"2021120822412620200_R128","doi-asserted-by":"crossref","unstructured":"Hunt CE, Corwin MJ, Lister G, et al. Longitudinal assessment of hemoglobin oxygen saturation in healthy infants during the first 6 months of age. Collaborative Home Infant Monitoring Evaluation (CHIME) Study Group. J Pediatr.\u20081999;135:580\u2013586","DOI":"10.1016\/S0022-3476(99)70056-9"},{"key":"2021120822412620200_R129","doi-asserted-by":"crossref","unstructured":"Young S, O'Keeffe PT, Arnott J, Landau LI. Lung function, airway responsiveness, and respiratory symptoms before and after bronchiolitis. Arch Dis Child.\u20081995;72:16\u201324","DOI":"10.1136\/adc.72.1.16"},{"key":"2021120822412620200_R130","unstructured":"Forster RE II, Dubois AB, Briscoe WA, Fisher AB. The Lung: Physiologic Basis of Pulmonary Function Tests. Chicago, IL: Year Book Medical Publishers, Inc; 1986"},{"key":"2021120822412620200_R131","unstructured":"Chernick V, Boat TF. Kendig's Disorders of the Respiratory Tract in Children. Philadelphia, PA: W.B. Saunders Co; 1998"},{"key":"2021120822412620200_R132","unstructured":"Salyer JW. Neonatal and pediatric pulse oximetry. Respir Care.\u20082003;48:386\u2013396; discussion 397\u2013398"},{"key":"2021120822412620200_R133","unstructured":"Groothuis JR, Gutierrez KM, Lauer BA. Respiratory syncytial virus infection in children with bronchopulmonary dysplasia. Pediatrics.\u20081988;82:199\u2013203"},{"key":"2021120822412620200_R134","doi-asserted-by":"crossref","unstructured":"Grimaldi M, Gouyon B, Michaut F, Huet F, Gouyon J; Burgundy Perinatal Network. Severe respiratory syncytial virus bronchiolitis: epidemiologic variations associated with the initiation of palivizumab in severely premature infants with bronchopulmonary dysplasia. Pediatr Infect Dis J.\u20082004;23:1081\u20131085","DOI":"10.1097\/01.inf.0000145406.74341.c7"},{"key":"2021120822412620200_R135","doi-asserted-by":"crossref","unstructured":"Horn SD, Smout RJ. Effect of prematurity on respiratory syncytial virus hospital resource use and outcomes. J Pediatr.\u20082003;143(5 suppl):S133\u2013S141","DOI":"10.1067\/S0022-3476(03)00509-2"},{"key":"2021120822412620200_R136","unstructured":"American Academy of Pediatrics. Red Book: 2006 Report of the Committee on Infectious Diseases. 27th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2006"},{"key":"2021120822412620200_R137","doi-asserted-by":"crossref","unstructured":"The IMpact-RSV study group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics.\u20081998;102:531\u2013537","DOI":"10.1542\/peds.102.3.531"},{"key":"2021120822412620200_R138","doi-asserted-by":"crossref","unstructured":"Feltes TF, Cabalka AK, Meissner HC, et al. Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease. J Pediatr.\u20082003;143:532\u2013540","DOI":"10.1067\/S0022-3476(03)00454-2"},{"key":"2021120822412620200_R139","doi-asserted-by":"crossref","unstructured":"Romero JR. Palivizumab prophylaxis of respiratory syncytial virus disease from 1998 to 2002: results from four years of palivizumab usage. Pediatr Infect Dis J.\u20082003;22(2 suppl):S46\u2013S54","DOI":"10.1097\/01.inf.0000053885.34703.84"},{"key":"2021120822412620200_R140","unstructured":"Hay JW, Ernst RL, Meissner HC. RSV-IGIV: a cost effectiveness analysis. Am J Manag Care.\u20081996;2:851\u2013861"},{"key":"2021120822412620200_R141","doi-asserted-by":"crossref","unstructured":"O'Shea TM, Sevick MA, Givner LB. Costs and benefits of respiratory syncytial virus immunoglobulin to prevent hospitalization for lower respiratory tract illness in very low birth weight infants. Pediatr Infect Dis J.\u20081998;17:587\u2013593","DOI":"10.1097\/00006454-199807000-00003"},{"key":"2021120822412620200_R142","doi-asserted-by":"crossref","unstructured":"Robbins JM, Tilford JM, Jacobs RF, Wheeler JG, Gillaspy SR, Schutze GE. A number-needed-to-treat analysis of respiratory syncytial virus immune globulin intravenous to prevent hospitalization [published correction appears in Arch Pediatr Adolesc Med. 1998;152:577]. Arch Pediatr Adolesc Med.\u20081998;152:358\u2013366","DOI":"10.1001\/archpedi.152.4.358"},{"key":"2021120822412620200_R143","doi-asserted-by":"crossref","unstructured":"Atkins JT, Karimi P, Morris BH, McDavid G, Shim S. Prophylaxis for RSV with RSV-IGIV among preterm infants of thirty-two weeks gestation and less: reduction in incidence, severity of illness and cost. Pediatr Infect Dis J.\u20082002;19:138\u2013143","DOI":"10.1097\/00006454-200002000-00012"},{"key":"2021120822412620200_R144","doi-asserted-by":"crossref","unstructured":"Thomas M, Bedford-Russell A, Sharland M. Hospitalization for RSV infection in ex-preterm infants: implications for use of RSV-IGIV. Arch Dis Child.\u20082000;83:122\u2013127","DOI":"10.1136\/adc.83.2.122"},{"key":"2021120822412620200_R145","doi-asserted-by":"crossref","unstructured":"Joffe S, Ray GT, Escobar GJ, Black SB, Lieu TA. Cost-effectiveness of RSV prophylaxis among preterm infants. Pediatrics.\u20081999;104:419\u2013427","DOI":"10.1542\/peds.104.3.419"},{"key":"2021120822412620200_R146","unstructured":"Stevens TP, Sinkin RA, Hall CB, Maniscalco WM, McConnochie KM. Respiratory syncytial virus and premature infants born at 32 weeks' gestation or earlier: hospitalization and economic implications of prophylaxis. Arch Pediatr Adolesc Med.\u20082000;154:55\u201361"},{"key":"2021120822412620200_R147","doi-asserted-by":"crossref","unstructured":"Kamal-Bahl S, Doshi J, Campbell J. Economic analysis of respiratory syncytial virus immunoprophylaxis in high-risk infants. Arch Pediatr Adolesc Med.\u20082002;156:1034\u20131041","DOI":"10.1001\/archpedi.156.10.1034"},{"key":"2021120822412620200_R148","doi-asserted-by":"crossref","unstructured":"Aintablian N, Walpita P, Sawyer MH. Detection of Bordetella pertussis and respiratory synctial virus in air samples from hospital rooms. Infect Control Hosp Epidemiol.\u20081998;19:918\u2013923","DOI":"10.1086\/647764"},{"key":"2021120822412620200_R149","doi-asserted-by":"crossref","unstructured":"Hall CB. Nosocomial respiratory syncytial virus infections: the \u201cCold War\u201d has not ended. Clin Infect Dis.\u20082000;31:590\u2013596","DOI":"10.1086\/313960"},{"key":"2021120822412620200_R150","doi-asserted-by":"crossref","unstructured":"Sattar SA, Terro J, Vashon R, Keswick B. Hygienic hand antiseptics: should they not have activity and label claims against viruses?Am J Infect Control.\u20082002;30:355\u2013372","DOI":"10.1067\/mic.2002.124532"},{"key":"2021120822412620200_R151","unstructured":"Boyce JM, Pittet D; Healthcare Infection Control Practices Advisory Committee, HICPAC\/SHEA\/APIC\/IDSA Hand Hygiene Task Force. Guideline for hand hygiene in health-care settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC\/SHEA\/APIC\/IDSA Hand Hygiene Task Force. Society for Healthcare Epidemiology of America\/Association for Professionals in Infection Control\/Infectious Diseases Society of America. MMWR Recomm Rep. 200225;51(RR-16):1\u201345; quiz CE1\u2013CE4"},{"key":"2021120822412620200_R152","doi-asserted-by":"crossref","unstructured":"Isaacs D, Dickson H, O'Callaghan C, Sheaves R, Winter A, Moxon ER. Handwashing and cohorting in prevention of hospital acquired infections with respiratory syncytial virus. Arch Dis Child.\u20081991;66:227\u2013231","DOI":"10.1136\/adc.66.2.227"},{"key":"2021120822412620200_R153","doi-asserted-by":"crossref","unstructured":"Krasinski K, LaCouture R, Holzman RS, Waithe E, Bonk S, Hanna B. Screening for respiratory syncytial virus and assignment to a cohort at admission to reduce nosocomial transmission. J Pediatr.\u20081990;116:894\u2013898","DOI":"10.1016\/S0022-3476(05)80646-8"},{"key":"2021120822412620200_R154","doi-asserted-by":"crossref","unstructured":"Karanfil LV, Conlon M, Lykens K, et al. Reducing the rate of nosocomially transmitted respiratory syncytial virus [published correction appears in Am J Infect Control. 1999;27:303]. Am J Infect Control.\u20081999;27:91\u201396","DOI":"10.1016\/S0196-6553(99)70087-8"},{"key":"2021120822412620200_R155","doi-asserted-by":"crossref","unstructured":"Macartney KK, Gorelick MH, Manning ML, Hodinka RL, Bell LM. Nosocomial respiratory syncytial virus infections: the cost-effectiveness and cost-benefit of infection control. Pediatrics.\u20082000;106:520\u2013526","DOI":"10.1542\/peds.106.3.520"},{"key":"2021120822412620200_R156","doi-asserted-by":"crossref","unstructured":"McConnochie KM, Roghmann KJ. Breast feeding and maternal smoking as predictors of wheezing in children age 6 to 10 years. Pediatr Pulmonol.\u20081986;2:260\u2013268","DOI":"10.1002\/ppul.1950020503"},{"key":"2021120822412620200_R157","doi-asserted-by":"crossref","unstructured":"Strachan DP, Cook DG. Health effects of passive smoking. 1. Parental smoking and lower respiratory illness in infancy and early childhood. Thorax.\u20081997;52:905\u2013914","DOI":"10.1136\/thx.52.10.905"},{"key":"2021120822412620200_R158","doi-asserted-by":"crossref","unstructured":"Stocks J, Dezateux C. The effect of parental smoking on lung function and development during infancy. Respirology.\u20082003;8:266\u2013285","DOI":"10.1046\/j.1440-1843.2003.00478.x"},{"key":"2021120822412620200_R159","doi-asserted-by":"crossref","unstructured":"Shiva F, Basiri M, Sadeghi B, Padyab M. Effects of passive smoking on common respiratory symptoms in young children. Acta Paediatr.\u20082003;92:1394\u20131397","DOI":"10.1111\/j.1651-2227.2003.tb00821.x"},{"key":"2021120822412620200_R160","doi-asserted-by":"crossref","unstructured":"Nandapalan N, Taylor C, Scott R, Toms GL. Mammary immunity in mothers of infants with respiratory syncytial virus infection. J Med Virol.\u20081987;22:277\u2013287","DOI":"10.1002\/jmv.1890220312"},{"key":"2021120822412620200_R161","doi-asserted-by":"crossref","unstructured":"Chiba Y, Minagawa T, Mito K, et al. Effect of breast feeding on responses of systemic interferon and virus-specific lymphocyte transformation in infants with respiratory syncytial virus infection. J Med Virol.\u20081987;21:7\u201314","DOI":"10.1002\/jmv.1890210103"},{"key":"2021120822412620200_R162","doi-asserted-by":"crossref","unstructured":"Laegreid A, Kolsto Otnaess AB, Orstavik I, Carlsen KH. Neutralizing activity in human milk fractions against respiratory syncytial virus. Acta Paediatr Scand.\u20081986;75:696\u2013701","DOI":"10.1111\/j.1651-2227.1986.tb10276.x"},{"key":"2021120822412620200_R163","doi-asserted-by":"crossref","unstructured":"Pullan CR, Toms GL, Martin AJ, Gardner PS, Webb JK, Appleton DR. Breastfeeding and respiratory syncytial virus infection. Br Med J.\u20081980;281:1034\u20131036","DOI":"10.1136\/bmj.281.6247.1034"},{"key":"2021120822412620200_R164","doi-asserted-by":"crossref","unstructured":"Downham MAPS, Scott R, Sims DG, Webb JKG, Gardner PS. Breast-feeding protects against respiratory syncytial virus infections. Br Med J.\u20081976;2(6030):274\u2013276","DOI":"10.1136\/bmj.2.6030.274"},{"key":"2021120822412620200_R165","doi-asserted-by":"crossref","unstructured":"Bachrach VR, Schwarz E, Bachrach LR. Breastfeeding and the risk of hospitalization for respiratory disease in infancy: a meta-analysis. Arch Pediatr Adolesc Med.\u20082003;157:237\u2013243","DOI":"10.1001\/archpedi.157.3.237"},{"key":"2021120822412620200_R166","doi-asserted-by":"crossref","unstructured":"Cohen HA, Varsano I, Kahan E, Sarrell EM, Uziel Y. Effectiveness of an herbal preparation containing echinacea, propolis, and vitamin C in preventing respiratory tract infections in children: a randomized, double-blind, placebo-controlled, multicenter study. Arch Pediatr Adolesc Med.\u20082004;158:217\u2013221","DOI":"10.1001\/archpedi.158.3.217"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/118\/4\/1774\/1115614\/zpe01006001774.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/118\/4\/1774\/1115614\/zpe01006001774.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T01:32:48Z","timestamp":1683595968000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/118\/4\/1774\/69020\/Diagnosis-and-Management-of-Bronchiolitis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10,1]]},"references-count":166,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2006,10,1]]},"published-print":{"date-parts":[[2006,10,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2006-2223","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10,1]]}}}